Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District

Recruiting

• Conditions: Rare Malignant Neoplasm

• Registration Number: NCT06872853
• Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Brief Summary

The goal of this observational study is to collect structured data about diagnosis, treatment and follow-up of rare and highly complex neoplasms.

The study has a rerospective part that will consist in gathering data on patients accessing IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola from 01/01/2000 to 28/09/2017 and a prospective one ranging from 29/09/2017 to 31/12/2025.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-09-29
• Status Verified: 2025-03
• Study First Submitted: 2025-03-07
• Study First Submitted QC: 2025-03-07
• Last Update Submitted: 2025-03-07
• Study First Posted: 2025-03-12
• Last Update Posted: 2025-03-12
• Primary Completion: 2025-11-30
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1100

Inclusion Criteria

• patients with histologic diagnosis of rare or highly complex malignant neoplasm
• informed consent

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of different malignant rare neoplasms	Throughout the lenght of study, an average of 10 years	Description of types of tumours

Secondary Outcome Measures

Name	Time	Method
Response rate (RR)	Throughout the lenght of study, an average of 10 years	Response rate to different treatments (surgery, drugs)
Local recurrence rate	Throughout the lenght of study, an average of 10 years	Incidence of local recurrence
Progression-free survival (PFS)	Throughout the lenght of study, an average of 10 years	Progression-free survival (PFS) assessed for different types of rare malignant neoplasms
Overall survival (OS)	Throughout the lenght of study, an average of 10 years	OS assessed for different types of rare malignant neoplasms

Trial Locations

Locations (2)

Oncology Unit, IRCCS AOUBO Policlinico di S. Orsola; 🇮🇹 Bologna, BO, Italy

Thoracic Surgery Unit; 🇮🇹 Bologna, BO, Italy